Article info

Original research
High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial
Free

Authors

  1. Correspondence to Prof. Andrea Cortegiani, Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.), University of Palermo, Via del vespro 129, 90127, Palermo, Italy; andrea.cortegiani{at}unipa.it
View Full Text

Citation

Crimi C, Noto A, Madotto F on behalf of the COVID-HIGH Investigators, et al
High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial

Publication history

  • Received February 3, 2022
  • Accepted April 26, 2022
  • First published May 17, 2022.
Online issue publication 
March 15, 2023

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.